BRUKER CORP (BRKR) Stock
BRKR has an Alpha Score of 36 out of 100 (weak), computed on Nov 5, 2026 from 3 of 4 sub-scores. 3 members of Congress disclosed 4 trades in BRKR since 2019: 2 purchases and 2 sales, most recently Bob Gibbs (sale, Nov 27, 2020). 5 of the hedge funds AlphaScala tracks reported BRKR in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Viking Global Investors's at $53.77M. Company insiders reported 0 open-market buys and 3 sales on SEC Form 4 in the 90 days to Nov 6, 2026.
What is BRKR's Alpha Score?
How it works →Alpha Score of 36 reflects weak overall profile with strong momentum, poor value, poor quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 5, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded BRUKER CORP (BRKR)?
Most recent: Bob Gibbs (sale, Nov 27, 2020); records start Jun 24, 2019.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Bob Gibbs R-OH · House | 2020-11-27 | sale | $1k – $15k |
| Tom Carper D-DE · Senate | 2020-11-20 | purchase | $1k – $15k |
| Bob Gibbs R-OH · House | 2019-11-14 | purchase | $1k – $15k |
| Donna Shalala D-FL · House | 2019-06-24 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all BRKR political trades →Which hedge funds own BRKR?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Viking Global Investors Andreas Halvorsen | 893K | $53.77M | NEW |
| Citadel Ken Griffin | 178K | $10.72M | -9% |
| D.E. Shaw David Shaw | 136K | $8.18M | +196% |
| Marshall Wace | 99K | $5.96M | +16% |
| Bridgewater Associates Ray Dalio | 42K | $2.55M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are BRUKER CORP insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 15, 26 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | SELL | 2.0K | $106K |
| Aug 17, 26 | Pusch Wolfgang | President BMID Group | SELL | 3.5K | $198K |
| Aug 14, 26 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | SELL | 2.0K | $115K |
SEC Form 4 filings as of Nov 6, 2026
See cluster-buy signals across all tickers →What are BRKR's key statistics?
Key statistics as of Nov 5, 2026
How does BRKR's valuation compare with the Healthcare sector?
| Metric | BRKR | Healthcare median | Companies in median |
|---|---|---|---|
| Net margin | -2.03% | 4.31% | 164 |
| Return on equity | -2.93% | 5.47% | 185 |
| Dividend yield (payers) | 0.30% | 1.59% | 55 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 7, 2026). P/E excludes loss-making companies.
BRKR price chart
Powered by TradingViewWhat does BRUKER CORP do?
Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions that enable molecular and materials research across academic, governmental, and industrial laboratories worldwide. The company designs and distributes nuclear magnetic resonance spectrometers, mass spectrometry platforms, X-ray diffraction instruments, atomic force microscopes, and preclinical imaging systems such as micro-CT and MRI scanners. In addition to hardware, Bruker provides comprehensive software suites, applications support, training services, and long-term maintenance agreements to optimize instrument performance. The company serves diverse customer segments in the pharmaceutical, biotechnology, chemical, semiconductor, energy, and environmental sectors through four primary business segments: Bruker Scientific Instruments BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. With research and development, manufacturing, and service centers located throughout the Americas, Europe, and Asia, Bruker maintains a global infrastructure to support its worldwide customer base. Founded in 1960 and headquartered in Billerica, Massachusetts, the company continues to play a significant role in advancing scientific research and analysis globally.